Goldberg, M. S., Siegel, J. J., Ahmed, K., Kurley, S. J., & Farberg, A. S. (2022). A prospective clinical utility study demonstrates that physicians use the 40-gene expression profile (40-GEP) to guide clinical management decisions for Medicare-eligible patients with cutaneous squamous cell carcinoma (cSCC). SKIN The Journal of Cutaneous Medicine, 6(6), s95. https://doi.org/10.25251/skin.6.supp.95